XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Earnings per Share (Tables)
 6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth reconciliations of the numerators and denominators used to calculate basic and diluted earnings per Class A ordinary share for the three and six months ended June 30, 2022 and 2021 (in thousands, except per share amounts):
For the Three Months Ended June 30,For the Six Months Ended June 30,
2022202120222021
Numerator
Consolidated net income$491,597 $806,755 $619,680 $965,734 
Less: Net income attributable to Continuing Investors Partnerships119,224 212,961 139,886 251,506 
Less: Net income attributable to Legacy Investors Partnerships and RPSFT67,869 153,018 123,529 204,333 
Net income attributable to Royalty Pharma plc - basic304,504 440,776 356,265 509,895 
Add: Reallocation of net income attributable to non-controlling interest from the assumed conversion of Class B ordinary shares 119,224 212,961 139,886 251,506 
Net income attributable to Royalty Pharma plc - diluted$423,728 $653,737 $496,151 $761,401 
Denominator
Weighted average Class A ordinary shares outstanding - basic436,318 409,344 435,144 399,606 
Add: Dilutive effects as shown separately below
Class B ordinary shares exchangeable for Class A ordinary shares170,864 197,773 172,035 207,508 
Unvested RSUs32 46 28 37 
Weighted average Class A ordinary shares outstanding - diluted607,214 607,163 607,207 607,151 
Earnings per Class A ordinary share - basic$0.70 $1.08 $0.82 $1.28 
Earnings per Class A ordinary share - diluted$0.70 $1.08 $0.82 $1.25